spondylometaphyseal dysplasia with cone-rod dystrophy

Summary
Synonym
  • SMD-CRD
  • SMDCRD
  • spondylometaphyseal dysplasia-cone-rod dystrophy syndrome
Definition
A spondylometaphyseal dysplasia characterized by postnatal growth deficiency, profound short stature, rhizomelia with bowing of the lower extremities, platyspondyly with anterior vertebral protrusions, progressive metaphyseal irregularity and cupping with shortened tubular bones, and early-onset progressive visual impairment associated with a pigmentary maculopathy and electroretinographic evidence of cone-rod dysfunction that has_material_basis_in homozygous or compound heterozygous mutation in the PCYT1A gene on chromosome 3q29.
Super Class
autosomal recessive disease spondylometaphyseal dysplasia
Disease Ontology
DOID:0112300
Mondo Disease Ontology
MeSH
UMLS
ORDO
OMIM
GARD
Related Genes
Displaying 1 entry
Gene ID Gene Symbol Description Source
5130 PCYT1A phosphate cytidylyltransferase 1A, choline
Displaying 1 entry
Gene ID Gene Symbol Description Source
353380 Y18H1A.11 choline-phosphate cytidylyltransferase
The Human Phenotype Ontology
Displaying entries 1 - 10 of 59 in total
HPO ID HPO Term
HP:0000486 Strabismus
HP:0000505 Visual impairment
HP:0000539 Abnormality of refraction
HP:0000548 Cone/cone-rod dystrophy
HP:0000568 Microphthalmia
HP:0000589 Coloboma
HP:0000602 Ophthalmoplegia
HP:0000639 Nystagmus
HP:0000887 Cupped ribs
HP:0000926 Platyspondyly
Displaying 1 entry
Gene ID Gene Symbol Description
5130 PCYT1A phosphate cytidylyltransferase 1A, choline

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024